{"pmid":32504266,"title":"Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor.","text":["Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor.","Updates Surg","Gambato, Martina","Burra, Patrizia","32504266"],"journal":"Updates Surg","authors":["Gambato, Martina","Burra, Patrizia"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32504266","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1007/s13304-020-00804-8","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1668892488321990656,"score":9.490897,"similar":[{"pmid":32251539,"title":"COVID-19 and liver disease.","text":["COVID-19 and liver disease.","Since December 2019, patients with unexplained pneumonia have been found in Wuhan, Hubei Province, China, which was caused by a novel coronavirus that had not been previously identified (1). Tentatively defined as 2019 novel coronavirus (2019-nCoV), the pathogen has now been named Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) (2), while the disease termed Coronavirus Disease 2019 (COVID-19).","Liver Int","Sun, Jian","Aghemo, Alessio","Forner, Alejandro","Valenti, Luca","32251539"],"abstract":["Since December 2019, patients with unexplained pneumonia have been found in Wuhan, Hubei Province, China, which was caused by a novel coronavirus that had not been previously identified (1). Tentatively defined as 2019 novel coronavirus (2019-nCoV), the pathogen has now been named Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) (2), while the disease termed Coronavirus Disease 2019 (COVID-19)."],"journal":"Liver Int","authors":["Sun, Jian","Aghemo, Alessio","Forner, Alejandro","Valenti, Luca"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32251539","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1111/liv.14470","keywords":["covid-19","sars-cov-2","coronavirus","infection","liver disease"],"locations":["Wuhan","Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Mechanism","Treatment","Prevention"],"weight":1,"_version_":1666138490931249152,"score":49.048424},{"pmid":32277387,"pmcid":"PMC7146012","title":"Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.","text":["Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.","Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic.","Hepatol Int","Liu, Hongling","He, Xi","Wang, Yudong","Zhou, Shuangnan","Zhang, Dali","Zhu, Jiye","He, Qiang","Zhu, Zhijun","Li, Guangming","Sun, Libo","Wang, Jianli","Cheng, Gregory","Liu, Zhenwen","Lau, George","32277387"],"abstract":["Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic."],"journal":"Hepatol Int","authors":["Liu, Hongling","He, Xi","Wang, Yudong","Zhou, Shuangnan","Zhang, Dali","Zhu, Jiye","He, Qiang","Zhu, Zhijun","Li, Guangming","Sun, Libo","Wang, Jianli","Cheng, Gregory","Liu, Zhenwen","Lau, George"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277387","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s12072-020-10043-z","keywords":["2019-ncov","covid-19","liver transplantation","management"],"locations":["Beijing","China","Beijing"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Diagnosis","Treatment"],"weight":1,"_version_":1666138491597094912,"score":46.15143},{"pmid":32348791,"pmcid":"PMC7195341","title":"Clinical characteristics of COVID-19 patients with abnormal liver tests.","text":["Clinical characteristics of COVID-19 patients with abnormal liver tests.","J Hepatol","Chen, Peng","Zhou, Benhong","32348791"],"journal":"J Hepatol","authors":["Chen, Peng","Zhou, Benhong"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32348791","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.jhep.2020.04.028","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138494994481152,"score":45.70576},{"pmid":32329563,"title":"Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis.","text":["Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis.","At present, there is scarce information regarding the global prevalence of chronic liver disease in individuals with coronavirus disease 2019 (COVID-19) disease, which is becoming a global pandemic. The aim of this study was to assess the overall prevalence of chronic liver disease among patients with COVID-19 disease by meta-analysing data in observational studies and to investigate the relationship between liver damage and COVID-19 disease. We included 11 observational studies for a total of 2034 adult individuals (median age 49 years [IQR 45-54], 57.2% men). The overall prevalence of chronic liver disease at baseline was 3% (95% CI 2%-4%; I(2) = 29.1%). Individuals with severe COVID-19 disease had relevant alterations of liver enzymes and coagulative profile, probably due to the innate immune response against the virus. Further studies are needed to better investigate the causes of liver injury in patients with COVID-19 disease and the effect of treatment for COVID-19 on the liver.","Liver Int","Mantovani, Alessandro","Beatrice, Giorgia","Dalbeni, Andrea","32329563"],"abstract":["At present, there is scarce information regarding the global prevalence of chronic liver disease in individuals with coronavirus disease 2019 (COVID-19) disease, which is becoming a global pandemic. The aim of this study was to assess the overall prevalence of chronic liver disease among patients with COVID-19 disease by meta-analysing data in observational studies and to investigate the relationship between liver damage and COVID-19 disease. We included 11 observational studies for a total of 2034 adult individuals (median age 49 years [IQR 45-54], 57.2% men). The overall prevalence of chronic liver disease at baseline was 3% (95% CI 2%-4%; I(2) = 29.1%). Individuals with severe COVID-19 disease had relevant alterations of liver enzymes and coagulative profile, probably due to the innate immune response against the virus. Further studies are needed to better investigate the causes of liver injury in patients with COVID-19 disease and the effect of treatment for COVID-19 on the liver."],"journal":"Liver Int","authors":["Mantovani, Alessandro","Beatrice, Giorgia","Dalbeni, Andrea"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32329563","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/liv.14465","topics":["Treatment"],"weight":1,"_version_":1666138494620139521,"score":45.192528},{"pmid":32489653,"pmcid":"PMC7242011","title":"Interrelationship Between Coronavirus Infection and Liver Disease.","text":["Interrelationship Between Coronavirus Infection and Liver Disease.","Clin Liver Dis (Hoboken)","Schaefer, Esperance A K","Arvind, Ashwini","Bloom, Patricia P","Chung, Raymond T","32489653"],"journal":"Clin Liver Dis (Hoboken)","authors":["Schaefer, Esperance A K","Arvind, Ashwini","Bloom, Patricia P","Chung, Raymond T"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32489653","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/cld.967","topics":["Diagnosis","Treatment","Mechanism"],"weight":1,"_version_":1668623433709125632,"score":44.983425}]}